SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 50 filers reported holding SATSUMA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $207,545 | -21.0% | 297,129 | +1.8% | 0.00% | 0.0% |
| Q4 2022 | $262,751 | +317.1% | 291,946 | +2672.8% | 0.00% | – |
| Q3 2022 | $63,000 | +10.5% | 10,529 | -23.0% | 0.00% | – |
| Q2 2022 | $57,000 | -70.6% | 13,669 | -73.2% | 0.00% | -100.0% |
| Q1 2022 | $194,000 | -56.4% | 51,074 | -48.4% | 0.00% | 0.0% |
| Q4 2021 | $445,000 | -28.7% | 98,947 | -26.2% | 0.00% | 0.0% |
| Q3 2021 | $624,000 | -70.6% | 134,011 | -55.4% | 0.00% | -80.0% |
| Q2 2021 | $2,120,000 | +73.9% | 300,699 | +45.8% | 0.01% | +66.7% |
| Q1 2021 | $1,219,000 | +271.6% | 206,240 | +190.0% | 0.00% | +200.0% |
| Q4 2020 | $328,000 | -67.2% | 71,110 | -72.4% | 0.00% | -75.0% |
| Q3 2020 | $1,001,000 | – | 257,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,118,761 | $14,533,000 | 3.83% |
| Ghost Tree Capital, LLC | 904,225 | $4,214,000 | 1.23% |
| RA Capital Management | 5,914,252 | $27,560,000 | 0.38% |
| Vivo Capital, LLC | 1,232,394 | $5,743,000 | 0.26% |
| Nan Fung Group Holdings Ltd | 142,900 | $666,000 | 0.21% |
| Ikarian Capital, LLC | 629,384 | $2,934,000 | 0.21% |
| NEA Management Company, LLC | 3,142,958 | $14,646,000 | 0.17% |
| SAMLYN CAPITAL, LLC | 1,716,067 | $7,998,000 | 0.11% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $8,788,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 90,665 | $422,000 | 0.04% |